BlackThorn Therapeutics

formerly BlackThornClosed

Transforming lives with neurobehavioral therapies

San Francisco, United States · Founded 2014 · $130.0M raised

Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$130.0M
Last Round
$76.0M Series BJun 2019
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

BlackThorn Therapeutics was a clinical-stage biopharmaceutical company dedicated to developing novel treatments for neurobehavioral disorders using its INFORM platform linking brain physiology to behavior. Founded in 2014 by Alex Tkachenko and Ed Roberts in San Francisco, the company raised $130M across four rounds including a $76M Series B. BlackThorn was later rebranded as Neumora Therapeutics, advancing its lead NOPR antagonist program into Phase 2 clinical trials.

Summary

BlackThorn Therapeutics is a Biotech company based in San Francisco, United States, founded in 2014. It has raised $130.0M in total across 3 rounds, most recently a $76.0M Series B round in Jun 2019. Investors include GV, ARCH Venture Partners and Polaris Partners.

Funding History

Series BSeries BJun 2019
$76.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BlackThorn Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/blackthorn-therapeutics"><img src="https://indexed.vc/api/badge/company/blackthorn-therapeutics" alt="BlackThorn Therapeutics on Indexed.vc" width="260" height="76" /></a>